Latest News about SPRC

Recent news which mentions SPRC

< Previous 1 2 3 4 5 6 7 8 Next >

SciSparc Reinforces Its New JV For Targeting Discovery With A Global Expert In The Field Of Mitochondrial Transport Proteins

June 15, 2022

93 Biggest Movers From Yesterday

June 14, 2022

70 Stocks Moving In Monday's Mid-Day Session

June 13, 2022

EXCLUSIVE: SciSparc' Board To Review Potential Strategic Transactions

June 09, 2022

Psyched: Christie's Launches NFT Collection Supporting Psychedelic Science, Origin's Listing On CSE Gives Retail Investors Access To Private Companies

June 08, 2022

Initial Positive Results For Cocaine Addiction Treatment Announced

June 08, 2022

SciSparc Ltd. Announces Initial Positive Results For The Cocaine Addiction Treatment Of Clearmind Medicine Inc.

June 07, 2022

SciSparc & Clearmind Medicine Team Up On Patent For Psychedelic Combination To Treat Cocaine Addiction

June 02, 2022

SciSparc Ltd. and Clearmind Medicine Inc. Collaboration Yields Another Patent Application for their Proprietary Psychedelic Combination to Treat Cocaine Addiction

June 02, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

June 01, 2022

SciSparc To Collaborate With Polyrizon For Brain Targeting Using Intranasal Hydrogel Systems

May 31, 2022

70 Biggest Movers From Friday

May 31, 2022

SciSparc Announces $10M Private Offering

May 27, 2022

SciSparc Gets Ethics Committee Approval In Germany And Israel Sites To Conduct A Phase IIb Trial In Tourette Syndrome

May 27, 2022

20 Stocks Moving in Friday's Pre-Market Session

May 27, 2022

88 Biggest Movers From Yesterday

May 27, 2022

Mid-Afternoon Market Update: Dow Surges 575 Points; Apyx Medical Shares Spike Higher

May 26, 2022

Mid-Day Market Update: Crude Oil Jumps Over 3%; NRx Pharmaceuticals Shares Tumble

May 26, 2022

61 Stocks Moving In Thursday's Mid-Day Session

May 26, 2022

Mid-Morning Market Update: Markets Open Higher; US Economy Contracts 1.5% In Q1

May 26, 2022

SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial In Tourette Syndrome

May 26, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

May 26, 2022

20 Stocks Moving in Thursday's Pre-Market Session

May 26, 2022

88 Biggest Movers From Yesterday

May 26, 2022

50 Stocks Moving In Wednesday's Mid-Day Session

May 25, 2022

Positive Phase 2 Results Of SciSparc's Cannabinoid-Based Drug Candidate May Offer Some New Hope To Tourette Syndrome Patients

May 25, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

May 25, 2022

21 Stocks Moving in Wednesday's Pre-Market Session

May 25, 2022

71 Biggest Movers From Yesterday

May 25, 2022

Mid-Afternoon Market Update: Nasdaq Down 300 Points; America's Car-Mart Shares Spike Higher

May 24, 2022

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.